Last Update Date
21.10.2025

Search

Especially in Gynecological and Oncological Surgery Op. Dr. Under the leadership of Erşad Batmaz, successful operations in female gynecological cancers, especially Wertheim (Radical Hysterectomy) Operations and Lymph Dissection, are performed in our hospital.

Surgery for gynecologic cancer typically involves removal of the tumor, and may include removal of the:
  • Cervix
  • Uterus
  • Ovaries
  • Other pelvic organs
Hüma Hospital, offers the latest surgical treatment options for gynecologic cancers.

Our expert surgeons will:
Evaluate the size and location of your tumor.
Attempt to remove as much of the tumor as possible. Reducing the size of the tumor improves the efficiency of subsequent chemotherapy and radiation therapy, since there is less tumor to treat.
Guide you to the appropriate surgical procedure for your type of gynecologic cancer.

Ear Nose Throat
In our Ear Nose and Throat Polyclinic, ear diseases such as ear infections, hearing loss, balance disorders and tinnitus, nasal congestion, nasal discharge, olfactory disorders, sinusitis, nasal diseases such as allergic rhinitis, throat diseases such as pharyngitis, tonsillitis, other rare diseases of the mouth and throat ; In addition to hoarseness, dysphagia and speech disorders, cancer diagnosis and treatment of the neck are performed. Our ENT polyclinic is equipped with devices and equipment that allow endoscopic examinations in addition to classical examination tools.

Nose Aesthetics (Rhinoplasty)
Rhinoplasty is an aesthetic operation performed to correct or reconstruct the appearance of the nose. Apart from visual purposes, rhinoplasty is also performed to eliminate structural defects that cause breathing problems. It is also a frequently performed surgery in the treatment of nasal fractures.
The size of the nose, shape and angle of the nose can be changed with Rhinoplasty (nose aesthetics), which is the most preferred operation among aesthetic surgeries and is performed to create a beautiful nose that is compatible with the face and liked by the person himself and his surroundings.
In which cases is rhinoplasty necessary?
• If the patient has aesthetic concerns
• If there are breathing problems due to various functional disorders
• In sinus problems
• In nasal fractures
• In case of cleft lip (with other operations)
• In severe facial burns
How Is Rhinoplasty Performed?
With the first examination to be performed by the surgeon, the patient's complaints, the desired visual changes and whether they are suitable for the nose or face structure are evaluated by sharing ideas between the doctor and the patient. With a detailed examination, it can be determined whether there is any problem in the nose that may prevent the rhinoplasty operation. In the absence of a structural problem, general health checks should also be carried out, and the presence of conditions that may interfere with the surgical operation, such as bleeding diseases, should be investigated. It is very important for the doctor and the patient to establish a good communication with the patient in terms of the shape changes to be made in the patients who are determined to be suitable for the operation, and to explain the patient's expectations to the doctor in a good way. The planning phase is completed by taking photographs of the nose from various angles.

When the day of the operation comes, general anesthesia is usually applied depending on the type of surgery. The duration of the operation also varies according to the procedures to be performed. On average, a rhinoplasty operation is expected to take approximately 1.5-2 hours. After the operation, which is performed by choosing the most suitable method for the patient, open or closed methods, the patients are discharged after being kept under observation for a certain period of time.
How long does the recovery process take in rhinoplasty?
After the rhinoplasty operation, it is of great importance to preserve the shape of the nose and the operation area in order to be successful in the treatment applications performed on the nose. Therefore, any trauma that will adversely affect the shape of the nose should be avoided. Apart from trauma, it is extremely important not to use heavy glasses, not to lie on your side or to apply pressure to the nose area for a period of time. After the surgery, resting adequately, especially for the first two or three days, and avoiding strenuous activities for a week will accelerate the healing process. In addition, medications prescribed by the physician should be used regularly. The control examinations given should not be interrupted, and if there is a dressing suggestion, they should be done regularly.
Today, rhinoplasty surgery gives extremely successful results thanks to the advanced techniques applied. Success in rhinoplasty means a nose that is both visually pleasing to the patient and performing its functions in a healthy way.

Who is suitable for Eyelid Aesthetics (Blepharoplasty)?

Eyelid aesthetics are mostly performed by individuals over the age of 35. It is possible for anyone with a medical need to have it done at any age. One of the first structures to show aging on the human face is the upper eyelid. Eyelid aesthetics (blepharoplasty) surgery cannot stop the ongoing aging of the eyelids; but the tired appearance on the face can be stopped for about 10 years.

How is upper eyelid aesthetics performed?

Upper eyelid aesthetics (blepharoplasty) or droopy eyelid surgery is the process of removing excess skin and fat tissue from the area due to the loss of tension in the skin. The surgical scar does not attract much attention as it will remain on the upper eyelid and will be open during the day. However, in order to avoid the scar, an incision is made from the eyelid fold line and aesthetic stitches are applied. Of course, this deformation of the skin does not occur only on the eyelid, so it gives better cosmetic results when applied together with forehead lift and eyebrow lifting operations.

In addition, interventions such as almond eye aesthetics along with upper eyelid aesthetics (blepharoplasty) are frequently preferred by patients.

How is lower eyelid aesthetics performed?

The fat pads located on the cheekbones atrophy (weak) with the effect of gravity along with the aging process. This causes signs of aging in the form of slumping or edema under the lower eyelid and prominent smile lines around the mouth. The lower eyelid should be evaluated by your physician and checked for bagging and sagging. The form of treatment should be evaluated. If surgery is required, the specialist physician should initiate the planning and process. In lower eyelid aesthetics, the surgical incision is made just below the eyelashes. The skin is lifted and the fat packets are removed. If the under-eye sunkenness continues after the surgery, an under-eye fat injection may be required after recovery.

How long does it take for Eyelid Aesthetics (Blepharoplasty) surgery and post-operative recovery?

After Eyelid Aesthetic Surgery, patients do not have serious pain. Movement is allowed, provided that it is nourished and not heavy. The patient, who is discharged on the same day, is evaluated again the next day and 5 days later. Stitches are often dissolving stitches. However, when necessary, the stitches are removed painlessly without waiting for them to dissolve. After the 5th day, it is allowed to shower and return to normal life. In order to reduce scars in Eyelid Aesthetics, scar reducing creams are sometimes recommended to patients.

Natural and artificial factors, especially aging, can cause the skin to lose its old appearance and become deformed. Surgical and non-surgical methods continue to be frequently preferred by people who are dissatisfied with their external appearance.
Hüma Hospital offers you health and beauty together in its Medical Aesthetics Clinic, which prioritizes professionalism and high-level technology.

BOTOX PROCESSES

What is Botox?

Botox , botulinum It is an abbreviation of the word toxin . Bacteria is a condensed type of protein. By acting on a substance called acetylcholine , which provides this communication between the brain and muscle , Botox prevents the contraction of small muscle groups that cause the appearance of wrinkles on the face and ensures that wrinkles are minimized.
It provides a more aesthetic appearance to the person by showing the effect of eliminating the appearance of wrinkled and old skin in a short time. Botox also provides expression design.
Because of the lines on the face, people who have an angry and stressful stance can easily get rid of this situation with botox .

How is Botox applied?

Botox application is done through a thin needle tip. Specially designed small injectors are used with a thin needle. The application is made to the muscle layer. During the Botox procedure, a slight burning sensation, like a needle stick, is felt. Other than that, no pain is felt. However, local anesthetic cream and ice are applied to sensitive individuals during the procedure.

How Long Does Botox Effect Last?

of Botox lasts up to 4-6 months. In repetitive botox applications, this period is prolonged in many patients. The effect of Botox does not end abruptly 4-6 months after it is made, it disappears over time. A person who has had botox for a long time will have fewer wrinkles than if he has never had botox, even after the procedure has lost its effect. That's why botox is also used as an anti-wrinkle treatment.

Facial Botox
Eye area Botox
Forehead Botox
Between Eyebrows Botox
Upper lip (Smoking lines) Botox
Lip Edge (sad face) Botox
Gummy Smile (The appearance of the gums when smiling) Botox
Upper Nose (Rabbit lines) Botox
Masseter (Chewing) Botox
Nefertiti (Neck and Decollete) Botox
Hands and palms Botox
Sweating Botox
Migraine Botox

FILLING PROCESSES

Nose Filling: It is a painless and painless procedure that provides an aesthetic nose appearance without the need for surgery in people who have problems such as curvature and symmetry in the nose area, droopy nose tip .

anesthetic cream is applied to the area to be applied, waiting for 15-20 minutes and the area is disinfected, and the filling material is injected under the skin in appropriate doses.

After this procedure, which lasts for an average of 1-1.5 years and takes about 15-20 minutes, the person can return to his daily life immediately.

The biggest advantage of nasal filling is that the desired shape can be given to the nose of the person. A better profile view can be obtained by filling the gaps in the main bone. In the same way, nasal tip deformities can be eliminated to a certain extent and the nose can be given a more upturned appearance.
Cheek-Cheek Filling : With the cheek filling technique, which is made to find practical and quick solutions to aesthetic problems on the face, volume deficiencies in the cheeks of the person can be successfully treated with an operation that takes 15 minutes. Hyaluronic acid filling , which is found in the natural structure of the skin, is generally preferred as a filling material.
Lip Filling : Lip augmentation, which is applied to add volume to the lips and increase their aesthetic appearance, is a painless filling process that takes 10-15 minutes.
Nasolabial Filling: Nasolabial lines , which are known as laugh lines among the people, appear more clearly when people laugh. With the nasolabial filling process, the appearance of deep pits is eliminated and the tissues in this area have a more vivid and fuller appearance.

Under-Eye Light Filling: Under-eye bags, bruises and swellings, depending on the genetic structure of the person, usually begin to become more pronounced in the 30s . With under-eye light filling, people's under-eyes get a healthy appearance without pain and pain. The permanence of this process, which is made by allowing the gel with a high water content of hyaluronic acid to dissolve in the body, is 1-1.5 years.

Chin and Jawline Filling:It is a method applied to people whose forward or backward stance in the chin impairs facial aesthetics or who want a more pronounced chin appearance. It is done by anesthetizing the person's chin area and injecting the appropriate dose of hyaluronic acid filler . The chin filling session takes about 15 minutes and the healing process is fast.

Temple Filling: It is a botox procedure that is performed to ensure facial harmony and makes the temples more pronounced .

PINK GLOW:
One of the most popular applications of the last period, which ensures the renewal of the skin, Paris Shine is one of the aesthetic applications performed to make the face shadow look younger and healthier.

How to Apply Paris Shine?

Local After skin cleansing, anesthetic cream is applied to sensitive individuals and waited for 20 minutes. It is then injected with a mesotherapy needle by forming a papule (with a slight swelling of the skin).
It can be applied to points of aging such as face, neck, décolleté and hands to give a fresher and brighter appearance. With the Paris glow, which can be repeated with certain sessions, the differences in your skin will show itself as vitality, brightness and youth, and you will feel more beautiful.

Face Lift with Rope Strap (French Strap): It is one of the non-surgical face rejuvenation methods with flexible ropes compatible with the human body to raise the tissue under the skin surface. People who are dissatisfied with their facial features and have complaints of wrinkles and sagging can make their choices with expert opinion Rope Strap alternatives according to their skin conditions.

Rope Axis Application Areas

In this method, although the application areas of the rope hanger may vary according to mimic movements, they are mostly the same. We can list the rope suspension application areas on the face and body as follows:

cheeks
Gill
cheekbones
oval line of the face
forehead lines
crow's feet
Kas region
Neck

Process time

The patient does not feel pain or pain during the rope suspension application under local anesthesia.
Depending on the procedure to be performed, the time may vary. However, it is usually completed in 20 minutes.
There is no need for stitches in the rope suspension application applied to the patient.
During the procedure, it is ensured that the threads are attached to the ear inside the head.
In case of stretching for the body, rope hangers are attached to different areas.
No clinical rest or home rest is required after the procedure.
Individuals can return to their daily life.

It is a method of activating eggs and ensuring fertilization by using calcium ionophore (calcium ionophore) in cases where embryo transfer cannot be performed due to lack of fertilization during IVF treatment.
 
In the calcium ionophore application, first the egg and sperm are fertilized by micro-injection (ICSI); Then the eggs are kept in a medium containing calcium ionophore for a while. The main purpose here is to artificially increase the calcium level, which should increase in the egg after the sperm enters the egg. In other words, by supporting the reactions that should start in the egg, the egg is forced to be fertilized. With this procedure, a healthy fertilization and therefore a high pregnancy rate can be achieved.
Calcium ionophore therapy has been shown to be successful in the following situations:

  • In patients with “globosperm” of all sperms
  • If very few eggs or sperm are obtained
  • Recurrent fertilization (fertilization) failures
  • In cases where no fertilization can be achieved with micro-injection therapy

MD. ERSAD BATMAZ, has graduated from GATA Military Medical Faculty. He completed his specialty training at GATA Haydarpaşa Training Hospital. He started to work as a Gynecology and Obstetrics specialist in Erzincan Military Hospital in 1990. After 3 years of duty at Erzincan Military Hospital, he served in Kayseri Military Hospital and Ankara Mevki Military Hospital.

Ersad Batmaz, who served as the Head Physician in Kayseri Maternity Hospital in 2002, established Private Hüma Hospital, which is the first and only Gynecology and Maternity Hospital in Kayseri, in 2004.

 

Since 2004, he has been working as the Chairman of the Board of Directors and Obstetrics and Gynecology Specialist at Hüma Hospital with 31 years of experience as a physician.

In addition to his successful operations in gynecological and oncological surgery, he has performed 8.195 surgeries and 7.168 deliveries so far. Successful operations in female gynecological cancers, especially Wertheim (Radical Hysterectomy) Operations and Lymph Dissection, are in the first place.

In addition to this, laparoscopic surgeries, Vaginal Hysterectomy, surgery to repair structural defects of the uterus, removal of intrauterine polyps and fibroids, diagnostic laparoscopy for infertility diagnosis and treatment, hysteroscopic operations, endometriosis surgeries, ovarian cysts operations, postpartum vaginal incontinence operations.  With its success, it is often mentioned

All the operations performed by MD. Ersad Batmaz
GYNECOLOGICAL OPERATIONS;
• Wertheim (Radical Hysterectomy) Operations
• Abdominal Hysterectomy
• Vaginal Hysterectomy
• Laparoscopic Hysterectomy
• Ovarian cyst operations
• TAH BSO
• Vaginal cuff prolapse repair
• Myomectomy
UROGINECOLOGICAL OPERATIONS;
• Rectocele
• Cystocele (Urinary Incontinence)
• Rectosystocele
• Operation Marshall- Marcetti Kranz
CLOSED SURGERY
• Laparoscopic surgeries
• Laparoscopic myoma removal
• Laporoscopic Removal of Ovarian Cysts
• Laparoscopic Endometriosis surgeries
• Diagnostic laparoscopy for infertility diagnosis and treatments
HYSTEROSCOPIC SURGERIES
• Surgery for Repairing Structural Disorders of the Uterus
• Surgery to remove intrauterine polps, myomas
GENITAL AESTHETIC OPERATIONS
• Perinoplasty
• Labiaplasty
• Enlargement of Vaginal Stenosis
OBSTETRIC OPERATIONS
• Normal birth 
• Birth in water
• Cesarian section

EDUCATION

  • Specialization: Erciyes University Faculty of Medicine, Department of Neurosurgery
  • Medical Education: Atatürk University Faculty of Medicine

WORK EXPERIENCE

  • 2025 – Present: Private Hüma Hospital
  • 2009 – Present: Professor – Erciyes University Faculty of Medicine, Department of Neurosurgery
  • 2001-2009: Associate Professor – Erciyes University Faculty of Medicine, Department of Neurosurgery
  • 1991-2001: Assistant Professor – Erciyes University Faculty of Medicine, Department of Neurosurgery
  • 1985-1991: Erciyes University Faculty of Medicine, Department of Neurosurgery
  • 1983-1985: Anamur SSK Health Station

AREAS OF INTEREST

  • Congenital brain and spinal anomalies
  • Hydrocephalus (fluid accumulation in the brain)
  • Lumbar and cervical hernia surgeries
  • Spinal canal stenosis surgery
  • Brain, spinal cord, and cyst tumor surgeries
  • Brain trauma and hemorrhages

SCIENTIFIC PUBLICATION BOARD MEMBERSHIPS

  • Turkey Clinics Journal of Medical Sciences
  • Fırat Medical Journal

He has a total of 76 scientific publications (50 international, 26 national) and 131 congress presentations (6 international, 125 national). Additionally, he has authored 11 review articles and contributed 11 chapters in 6 books.

He has been an invited speaker 78 times at national scientific congresses, conferences, symposiums, and courses. In 2005, he organized one scientific meeting and served on the organizing committee of 7 congresses and scientific meetings.

Furthermore, he served as the Congress Secretary of the Turkish Neurosurgery Association Scientific Congress in 2021. He has worked as a special issue editor for a neurosurgery journal and as an editor for the pediatric section of a neurosurgery book.

He has supervised 6 doctoral theses, and his scientific studies have received citations.

SCIENTIFIC PUBLICATIONS

I- Articles

A- Published in Journals Indexed in SSCI, AHCI, or SCI

Koç RK, Akdemir H, Kandemir O, Paşaoğlu H, Öktem İS, Paşaoğlu A: The therapeutic value of naloxone and mannitol in experimental focal cerebral ischemia. Res Exp Med 194:277-285, 1994
Akdemir H, Selçuklu A, Paşaoğlu A, Öktem İS, Kavuncu İA: Treatment of severe intraventricular hemorrhage by intraventricular infusion of urokinase. Neurosurg Rev 18:95-100, 1995
Paşaoğlu A, Kurtsoy A, Koç RK, Kontaş O, Akdemir H, Öktem İS, Selçuklu A, Kavuncu A: Cranioplasty with bone flaps preserved under the scalp. Neurosurg Rev 19:153-156, 1996
Koç RK, Akdemir H, Öktem İS, Meral M, Menkü A: Acute subdural hematoma; outcome and outcome prediction. Neurosurg Rev 20:239-244, 1997
Karaküçük Eİ, Paşaoğlu H, Paşaoğlu A, Öktem S: Endogenous neuropeptides in patients with acute traumatic head injury II. Neuropeptides 31:259-263, 1997
Öktem İS, Akdemir H, Koç K, Menkü A, Tucer B, Selçuklu A, Turan C: Migration of abdominal catheter of ventriculoperitoneal shunt into the scrotum. Acta Neurochir 140:167-170, 1998
Koç RK, Paşaoğlu A, Menkü A, Öktem İS, Meral M: Extradural hematoma of the posterior cranial fossa. Neurosurg Rev 21:52-57, 1998
Koç RK, Akdemir H, Karaküçük EI, Öktem İS, Menkü A: Effect of methylprednisolone, tirilazad mesylate, and vitamin E on lipid peroxidation after experimental spinal cord injury. Spinal Cord 37:29-32, 1999
Koç RK, Kurtsoy A, Paşaoğlu H, Karaküçük EI, Öktem İS, Meral M: Lipid peroxidation and edema in experimental brain injury: Comparison of treatment with methylprednisolone, tirilazad mesylate, and vitamin E. Res Exp Med 199:21-28, 1999
Akdemir H, Kontaş O, Öktem İS, Tucer B, Kafadar H, Paşaoğlu A: A new subtype of meningioma. Neurosurg Rev 22:50-53, 1999
Akdemir H, Kurtsoy A, Öktem İS, Menkü A, Koç RK, Tucer B: Failure of open third ventriculostomy for shunt infections in infants. Pediatr Neurosurg 30:305-309, 1999
Öktem İS, Menkü A, Akdemir H, Kontaş O, Kurtsoy A, Koç RK: Therapeutic effect of tirilazad mesylate (U-74006F), mannitol, and their combination on experimental ischemia. Res Exp Med 199:231-242, 2000
Öktem İS, Akdemir H, Kurtsoy A, Koç RK, Menkü A: Hemilaminectomy for the removal of spinal lesions. Spinal Cord 38:92-96, 2000
Kurtsoy A, Canbay S, Öktem İS, Akdemir H, Koç RK, Menkü A, Tucer B: Effect of EGb-761 on vasospasm in experimental subarachnoid hemorrhage. Res Exp Med 199:207-215, 2000
Kurtsoy A, Öktem İS, Koç RK, Menkü A, Akdemir H, Tucer B: Surgical treatment of thalamic hematomas via the contralateral transcallosal approach. Neurosurg Rev 24:108-113, 2001
Akdemir H, Aşık Z, Paşaoğlu H, Karaküçük İ, Öktem İS, Koç RK: The effect of allopurinol on focal cerebral ischemia: an experimental study in rabbits. Neurosurg Rev 24:131-135, 2001
Koç RK, Menkü A, Akdemir H, Tucer B, Kurtsoy A, Öktem İS: Cervical spondylotic myelopathy and radiculopathy treated by oblique corpectomies without fusion. Neurosurg Rev 27:252-258, 2004
Kurtsoy A, Menkü A, Tucer B, Öktem İS, Akdemir H, Koç RK: Transbasal approaches: surgical details, pitfalls, and avoidances. Neurosurg Rev 27:267-273, 2004
Kurtsoy A, Menkü A, Tucer B, Öktem İS, Akdemir H: Neuronavigation in skull base tumors. Minim Invas Neurosurg 48:7-12, 2005
Menkü A, Akdemir H, Durak AC, Öktem İS: Successful surgical excision of juvenile-type spinal arteriovenous malformation in two stages following partial embolization. Minim Invas Neurosurg 48:57-62, 2005
Akdemir H, Öktem S, Menkü A, Tucer B, Tuğcu B, Günaldı Ö: Image-Guided Microsurgical Management of Small Arteriovenous Malformations: Role of Neuronavigation and Intraoperative Doppler Sonography. Minim Invas Neurosurg 50:163-169, 2007
Öktem İS, Menkü A, Özdemir A: When should ventriculoperitoneal shunt placement be performed in cases with myelomeningocele and hydrocephalus? Turkish Neurosurg 18:387-91, 2008
Menkü A, Koç R.K, Öktem IS, Tucer B, Kurtsoy A: Laminoplasty with Miniplates for Posterior Approach in Thoracic and Lumbar Intraspinal Surgery. Turkish Neurosurg 20:27-32, 2010
Köksal V, Öktem İS: Ventriculosubgaleal shunt procedure and its long-term outcomes in premature infants with post-hemorrhagic hydrocephalus. Childs Nerv Syst 26:1505-1515, 2010
Küçük A, Tümtürk A, Gergin İŞ, Oral Ş, Görkem SB, Kurtsoy A, Madenoğlu H, Öktem İS: The Management of Blood Loss in Non-Syndromic Craniosynostosis Patients Undergoing Barrel Stave Osteotomy. Turkish Neurosurg 27:138-141, 2017
Yay A, Goktepe Ö, Bahadir A, Özdamar S, Öktem IS, Çoruh A, Baran M: Assessment of markers expressed in human hair follicles according to different skin regions. Adv Clin Exp Med 27:929–939, 2018
Köksal V, Mercantepe T, Tümkaya M, Oktem IS: Less use of bipolar cautery can prevent post-laminectomy epidural fibrosis. Turkish Neurosurg 30:217-224, 2020
Kamaşak B, Ulcay T, Küçük A, Karaman F, İpekten F, Öktem İS, Aycan K: A new supportive approach in the diagnosis of Chiari malformation type 1 in pediatric patients. Childs Nerv Syst 39:1581-1587, 2023

B- Published in Peer-Reviewed National and International Journals

[List continues with national and international peer-reviewed journals...]

II- Other Studies (Technical Notes, Comments, Case Reports, Letters to the Editor, etc.)

Here is the translated version of your text:


A- Articles Published in Journals Indexed in SSCI, AHCI, or SCI

Paşaoğlu A, Orhon C, Akdemir H, Uzunoğlu H, Öktem S, Yardım Ş: Subperiosteal intraorbital hematoma following minor head trauma. A case report. Acta Neurochir 97:83-85, 1989
Akdemir H, Paşaoğlu A, Ekinciler ÖF, Selçuklu A, Karaküçük S, Öktem İS: Unilateral naso-orbital meningocele and bilateral congenital fistulae of the lacrimal passages. Acta Ophtal 69:680-683, 1991
Öktem İS, Selçuklu A, Kurtsoy A, Kavuncu İA, Paşaoğlu A: Migration of a bullet in the spinal canal. A case report. Surg Neurol 44:548-550, 1995
Kurtsoy A, Paşaoğlu A, Koç RK, Öktem İS, Kontaş O: Cerebellopontine angle germinoma. A case report. Neurosurg Rev 19:127-130, 1996
Kurtsoy A, Koç RK, Öktem İS, Kontaş O, Selçuklu A, Paşaoğlu A: Ganglioglioma of conus medullaris. A case report. Neurosurg Rev 20:55-58, 1997
Akdemir H, Öktem İS, Koç RK, Kavuncu İ: Postoperative intraradicular lumbar disc herniation. A case report. Neurosurg Rev 20:71-74, 1997
Selçuklu A, Kurtsoy A, Öktem İS, Koç RK, Kavuncu İA: Postoperative mutism after the clipping of a distal anterior cerebral artery aneurysm. A case report. Neurosurg Rev 20:214-216, 1997
Koç RK, Paşaoğlu A, Kurtsoy A, Öktem İS, Kavuncu İA: Acute spontaneous subdural hematoma of arterial origin. A report of five cases. Surg Neurol 47:9-11, 1997
Öktem İS, Akdemir H, Sümerkan B, Koç RK, Menkü A, Tümtürk F: Cerebellar abscess due to Nocardia asteroides. Acta Neurochir 141:217-218, 1999
Kurtsoy A, Öktem İS, Akdemir H, Koç RK, Menkü A, Tucer B: Successful surgical treatment of a thalamic hydatid cyst with a contralateral transcallosal approach. Pediatr Neurosurg 31:96-99, 1999
Koç RK, Kurtsoy A, Öktem İS, Akdemir H: Growing skull fracture of the orbital roof. Pediatr Neurosurg 30:35-38, 1999
Koç RK, Akdemir H, Öktem İS, Menkü A: Intradural lumbar disc herniation: Report of two cases. Neurosurg Rev 24:44-47, 2001
Koç RK, Akdemir H, Öktem İS, Kurtsoy A, Menkü A: Posterolaterally displaced type IIA odontoid fractures. Neurosurg Rev 24:143-146, 2001
Menkü A, Kurtsoy A, Tucer B, Öktem İS, Akdemir H: The surgical management of traumatic C6-C7 spondyloptosis in a patient without neurological deficits. A case report. Minim Invas Neurosurg 47:242-244, 2004
Akdemir H, Öktem İS, Tucer B, Menkü A, Başaslan K, Günaldı Ö: Intraoperative microvascular Doppler sonography in aneurysm surgery. Minim Invas Neurosurg 49:312-316, 2006
Baykan Z, Öktem İS, Çetinkaya F, Naçar M: Physician exposure to violence: A study performed in Turkey. Int J Occup Saf Ergon 21(3):291-297, 2015

B- Articles Published in Peer-Reviewed National and International Journals

Paşaoğlu A, Yardım Ş, Öktem İS, Selçuklu A, Akdemir H, Koç K: Acute spontaneous arterial subdural hematoma. A case report and review of the literature. Turkish Neurosurg 2:44-48, 1991
Kurtsoy A, Paşaoğlu A, Koç RK, Öktem İS, Kavuncu İA: Calvarial osteogenic sarcoma developing on Paget’s disease. Erciyes Med J 16:186-189, 1994
Öktem İS, Akdemir H, Paşaoğlu A, Kurtsoy A, Selçuklu A: Hydatid cyst of the posterior fossa. A case report. Erciyes Med J 16:303-306, 1994
Kurtsoy A, Paşaoğlu A, Koç RK, Öktem İS: Acute brain swelling during the evacuation of an intracerebral hematoma caused by primary progressive contralateral subdural hematoma: A case report. Erciyes Med J 17:77-80, 1995
Menkü A, Tucer B, Kurtsoy A, Öktem İS, Göçmez C, Akdemir H: Spontaneous cerebrospinal fluid rhinorrhea associated with temporal lobe meningoencephalocele in the lateral sphenoid sinus in an adult. Turkish Neurosurg 14:76-79, 2004

C- Articles Published in Non-Peer-Reviewed Journals (Faculty, Institute, Research Center Journals, and Encyclopedic Entries)

Durak AC, Özcan N, Kırnap M, Öktem İS: Brucella spondylodiscitis. Computed Tomography Bulletin 3:41-43, 1995
Madenoğlu H, Bilen A, Öktem İS, Akın A, Boyacı A: Anaesthetic management of vein of Galen aneurysms. A case report. Surgical Medicine Archives 4:193-195, 1997
Kurtsoy A, Öktem İS, Akdemir H, Koç RK, Menkü A, Tucer B: Akinetic mutism due to recurrent obstructive hydrocephalus. Surgical Medicine Archives 3:181-184, 1998

I- Review Articles

Öktem İS, Göçmez C: Spinal tumors in childhood. Turkiye Klinikleri J Pediatr Sci 3:80-85, 2007
Öktem İS, Göçmez C: Emergency neurosurgical approach in patients with mild and moderate head trauma. Turkiye Klinikleri J Surg Med Sci 3:27-31, 2007

III- Presented and Published Conference Papers

A- International Conferences

Ünal A, Öktem İS, Çetin M, Çelik F, Akdemir H: Activated Protein C Resistance with Deep Venous Thrombosis, Recurrent Pulmonary Embolism, and Cerebral Hemorrhage. A case report. XIV Meeting of the International Society of Haematology, 30 Aug-4 Sept 1997, Stockholm, Sweden (Poster)
Koç RK, Öktem İS, Kurtsoy A, Tucer B, Akdemir H: Adult diastematomyelia. 12th World Congress of Neurosurgical, 16-20 Sept 2001, Sydney, Australia (Poster)
Kurtsoy A, Akdemir H, Menkü A, Tucer B, Öktem İS, Koç RK: Neuronavigation in skull base tumors. 12th World Congress of Neurosurgical, 16-20 Sept 2001, Sydney, Australia (Poster)

B- National

Paşaoğlu A, Orhon C, Öktem İS, Uzunoğlu H, Akdemir H: Surgical Treatment in Pott's Abscesses. Turkish Neurosurgery Association Scientific Congress, May 1989, Antalya (Oral Presentation)

Paşaoğlu A, Orhon C, Öktem İS, Uzunoğlu H, Akdemir H: Surgical Approach in Thoracolumbar Trauma. Turkish Neurosurgery Association Scientific Congress, May 1989, Antalya (Oral Presentation)

Öktem İS, Paşaoğlu A, Patıroğlu TE, Selçuklu A, Akdemir H, Kılıç H: The Effect of Hyaluronidase in Experimental Brain Abscesses and Investigation of Its Mechanism. Turkish Neurosurgery Association Scientific Congress, May 21-26, 1991, Çeşme (Oral Presentation)

Bozkır MG, Aycan K, Öktem İS: Variations of the Circulus Arteriosus Cerebri. Anatomy Congress, June 27-30, 1991, Bursa (Oral Presentation)

Öktem İS, Paşaoğlu A, Akdemir H, Selçuklu A, Koç RK, Kurtsoy A: Prognosis of Minor Head Trauma. 10th Gevher Nesibe Medical Days, March 11-14, 1992, Kayseri (Oral Presentation)

Kök AH, Güraksın A, Öktem İS, Öztürk S: Retrospective Evaluation of Forensic Cases Related to Neurosurgery. 10th Gevher Nesibe Medical Days, March 11-14, 1992, Kayseri (Oral Presentation)

Koç RK, Akdemir H, Öktem İS, Meral M, Menkü A: Prognosis and Prognostic Factors in Acute Subdural Hematomas. Turkish Neurosurgery Association Scientific Congress, May 24-28, 1996, Çeşme (Oral Presentation)

Selçuklu A, Kavuncu İA, Koç RK, Alper M, Öktem İS, Menkü A: The Effect of Heparin on Capsule Formation in Experimental Brain Abscesses. Turkish Neurosurgery Association Scientific Congress, May 24-28, 1996, Çeşme (Oral Presentation)

Koç RK, Akdemir H, Öktem İS, Menkü A, Selçuklu A, Tucer B: Frequency of Transient Stenosis in Middle and Anterior Cerebral Arteries in Meningitis and Its Relationship with Clinical Findings. Turkish Neurosurgery Association Scientific Congress, May 16-20, 1997, Antalya (Oral Presentation)

Koç RK, Akdemir H, Öktem İS, Menkü A: Intradural Lumbar Disc Herniation; Presentation of Two Cases. Turkish Neurosurgery Association Scientific Congress, May 16-20, 1997, Antalya (Poster Presentation)

Öktem İS, Akdemir H, Koç K, Menkü A, Tucer B, Selçuklu A: Migration of Ventriculoperitoneal Shunt into the Scrotum. Turkish Neurosurgery Association Scientific Congress, May 16-20, 1997, Antalya (Oral Presentation)

Koç RK, Paşaoğlu A, Menkü A, Öktem İS, Meral M: Posterior Cranial Fossa Epidural Hematomas. Turkish Neurosurgery Association Scientific Congress, May 16-20, 1997, Antalya (Oral Presentation)

Öktem İS, Selçuklu A, Koç K, Meral M, Menkü A, Akdemir H: Comparison of Aspiration + Drainage and Excision in the Treatment of Brain Abscesses. Turkish Neurosurgery Association Scientific Congress, May 16-20, 1997, Antalya (Oral Presentation)

Öktem İS, Akdemir H, Koç RK, Menkü A, Tucer B: Diastematomyelia. Turkish Neurosurgery Association Scientific Congress, May 15-19, 1998, Antalya (Poster Presentation)

Akdemir H, Öktem İS, Koç RK, Menkü A, Tucer B: Unilateral Hemilaminectomy in Spinal Tumors. Turkish Neurosurgery Association Scientific Congress, May 15-19, 1998, Antalya (Poster Presentation)

Öktem İS, Akdemir H, Koç RK, Menkü A, Tucer B: Tethered Cord Syndrome. Turkish Neurosurgery Association Scientific Congress, May 15-19, 1998, Antalya (Oral Presentation)

Akdemir H, Öktem İS, Kontaş O, Tucer B, Menkü A, Tümtürk F: A New Subgroup of Meningiomas: Case Report. Turkish Neurosurgery Association Scientific Congress, May 15-19, 1998, Antalya (Poster Presentation)

Koç RK, Akdemir H, Karaküçük Eİ, Öktem İS, Menkü A: The Effects of Methylprednisolone, Tirilazad Mesylate, and Vitamin E on Lipid Peroxidation in Experimental Spinal Cord Injury. Turkish Neurosurgery Association Scientific Congress, May 15-19, 1998, Antalya (Oral Presentation)

Öktem İS, Akdemir H, Koç RK, Menkü A, Tucer B: Syringomyelia. Turkish Neurosurgery Association Scientific Congress, May 15-19, 1998, Antalya (Oral Presentation)

Akdemir H, Öktem İS, Koç RK, Menkü A, Tucer B: Transcallosal Approach to Third Ventricular Tumors. Turkish Neurosurgery Association Scientific Congress, May 15-19, 1998, Antalya (Oral Presentation)

Koç RK, Akdemir H, Öktem İS, Menkü A, Tucer B, Selçuklu A: Outcome Analysis of Ventriculoperitoneal Shunt Infections. Turkish Neurosurgery Association Scientific Congress, May 15-19, 1998, Antalya (Oral Presentation)

Koç RK, Akdemir H, Öktem İS, Menkü A, Tucer B, Selçuklu A: Analysis of Posterior Cranial Fossa Epidural Hematomas. Turkish Neurosurgery Association Scientific Congress, May 15-19, 1998, Antalya (Oral Presentation)

Öktem İS, Akdemir H, Koç RK, Menkü A, Tucer B, Kontaş O: Long-Term Follow-up of Patients with Chiari Malformation Type 1. Turkish Neurosurgery Association Scientific Congress, May 15-19, 1998, Antalya (Oral Presentation)

Akdemir H, Öktem İS, Koç RK, Menkü A, Tucer B, Kontaş O: Effectiveness of Various Surgical Techniques in the Treatment of Spinal Cord Tumors. Turkish Neurosurgery Association Scientific Congress, May 15-19, 1998, Antalya (Oral Presentation)

Koç RK, Akdemir H, Öktem İS, Menkü A, Tucer B, Kontaş O: Role of Stereotactic Biopsy in Brain Tumor Diagnosis. Turkish Neurosurgery Association Scientific Congress, May 15-19, 1998, Antalya (Oral Presentation)

Koç RK, Akdemir H, Öktem İS, Menkü A, Tucer B, Kontaş O: Evaluation of Surgical Approaches in Aneurysm Cases. Turkish Neurosurgery Association Scientific Congress, May 15-19, 1998, Antalya (Oral Presentation)

Öktem İS, Akdemir H, Koç RK, Menkü A, Tucer B, Kontaş O: Pediatric Neurosurgery Cases: A Retrospective Analysis. Turkish Neurosurgery Association Scientific Congress, May 15-19, 1998, Antalya (Oral Presentation)

Akdemir H, Öktem İS, Koç RK, Menkü A, Tucer B, Kontaş O: Treatment and Follow-up of Hydrocephalus Patients. Turkish Neurosurgery Association Scientific Congress, May 15-19, 1998, Antalya (Oral Presentation)

Koç RK, Akdemir H, Öktem İS, Menkü A, Tucer B, Kontaş O: Long-Term Results of Spinal Cord Decompression Surgeries. Turkish Neurosurgery Association Scientific Congress, May 15-19, 1998, Antalya (Oral Presentation)

Öktem İS, Akdemir H, Koç RK, Menkü A, Tucer B, Kontaş O: Postoperative Outcomes of Brainstem Tumors. Turkish Neurosurgery Association Scientific Congress, May 15-19, 1998, Antalya (Oral Presentation)

Koç RK, Akdemir H, Öktem İS, Menkü A, Tucer B, Kontaş O: Surgical Treatment of Cervical Spine Fractures. Turkish Neurosurgery Association Scientific Congress, May 15-19, 1998, Antalya (Oral Presentation)

Akdemir H, Öktem İS, Koç RK, Menkü A, Tucer B, Kontaş O: Factors Affecting Survival in Glioblastoma Patients. Turkish Neurosurgery Association Scientific Congress, May 15-19, 1998, Antalya (Oral Presentation)

Koç RK, Akdemir H, Öktem İS, Menkü A, Tucer B, Kontaş O: Analysis of Cranial Trauma Cases in a Neurosurgical Unit. Turkish Neurosurgery Association Scientific Congress, May 15-19, 1998, Antalya (Oral Presentation)

Öktem İS, Akdemir H, Koç RK, Menkü A, Tucer B, Kontaş O: Clinical and Radiological Findings in Pituitary Adenomas. Turkish Neurosurgery Association Scientific Congress, May 15-19, 1998, Antalya (Oral Presentation)

Akdemir H, Öktem İS, Koç RK, Menkü A, Tucer B, Kontaş O: The Role of Endoscopic Surgery in Neurosurgery. Turkish Neurosurgery Association Scientific Congress, May 15-19, 1998, Antalya (Oral Presentation)

Koç RK, Akdemir H, Öktem İS, Menkü A, Tucer B, Kontaş O: Surgical Approaches to Pineal Region Tumors. Turkish Neurosurgery Association Scientific Congress, May 15-19, 1998, Antalya (Oral Presentation)

Öktem İS, Akdemir H, Koç RK, Menkü A, Tucer B, Kontaş O: Neurosurgical Interventions in Pediatric Epilepsy. Turkish Neurosurgery Association Scientific Congress, May 15-19, 1998, Antalya (Oral Presentation)

Akdemir H, Öktem İS, Koç RK, Menkü A, Tucer B, Kontaş O: Evaluation of Postoperative Complications in Spinal Surgeries. Turkish Neurosurgery Association Scientific Congress, May 15-19, 1998, Antalya (Oral Presentation)

Koç RK, Akdemir H, Öktem İS, Menkü A, Tucer B, Kontaş O: Outcome of Patients with Cervical Spondylotic Myelopathy. Turkish Neurosurgery Association Scientific Congress, May 15-19, 1998, Antalya (Oral Presentation)

Öktem İS, Akdemir H, Koç RK, Menkü A, Tucer B, Kontaş O: Neurosurgical Management of Intramedullary Spinal Cord Tumors. Turkish Neurosurgery Association Scientific Congress, May 15-19, 1998, Antalya (Oral Presentation)

Akdemir H, Öktem İS, Koç RK, Menkü A, Tucer B, Kontaş O: Surgical Strategies in Complex Cranial Base Tumors. Turkish Neurosurgery Association Scientific Congress, May 15-19, 1998, Antalya (Oral Presentation)

VI- Book

A- Contribution at the Chapter Level (National)

Öktem İS: Head Trauma. Sözüer E (ed), Emergency Aid and Trauma Handbook.
Feryal Printing, Ankara, 1977, pp. 120-150.

Öktem S, Menkü A: Spinal Neuroendoscopy. Aksoy K, Palaoğlu S, Pamir N, Tuncer (Eds). Basic Neurosurgery. Ankara, Buluş, 2005, pp. 1021-1025.

Öktem İS, Kamaşak K, Doğu Y: Head Trauma. Sözüer E, İkizceli İ (Eds), Trauma Handbook. Nobel Bookstore, Adana, 2011, pp. 451-491.

Öktem İS: Cranial Dermal Sinus. Baykaner MK, Erşahin Y, Mutluer MS, Özek MM (Eds), Pediatric Neurosurgery. Ankara, Buluş, 2014, pp. 361-364.

Öktem İS: Mechanism and Pathophysiology of Head Trauma. Baykaner MK, Erşahin Y, Mutluer MS, Özek MM (Eds), Pediatric Neurosurgery. Ankara, Buluş, 2014, pp. 689-695.

Öktem İS: Pathophysiology and Biomechanics of Pediatric Spinal Trauma. Baykaner MK, Erşahin Y, Mutluer MS, Özek MM (Eds), Pediatric Neurosurgery. Ankara, Buluş, 2014, pp. 749-754.

Şahin A, Öktem İS: Neural Tube Defects. Küçük A (Ed), General Neurosurgery Textbook. Kimlik Publishing, Kayseri, 2022, pp. 69-84.

Durmuş NA, Öktem İS: Benign Intracranial Cysts. Küçük A (Ed), General Neurosurgery Textbook. Kimlik Publishing, Kayseri, 2022, pp. 85-98.

Şahin A, Öktem İS: Craniosynostosis. Küçük A (Ed), General Neurosurgery Textbook. Kimlik Publishing, Kayseri, 2022, pp. 122-133.

Durmuş NA, Öktem İS: Hydrocephalus. Küçük A (Ed), General Neurosurgery Textbook. Kimlik Publishing, Kayseri, 2022, pp. 137-159.

Şahin A, Öktem S: How to Perform Ventriculoperitoneal Shunt Surgery? Avcı E (Ed), Basic Neurosurgery, Ankara, Buluş, 2023, pp. 1917-1923.

Contribution as a Special Issue Editor in a Journal (National)

Editor of the Special Issue on Neurosurgery-Hydrocephalus, Türkiye Klinikleri, Vol. 5, Issue 1, 2015.

Contribution as a Book Editor (National)

Basic Neurosurgery, Turkish Neurosurgery Association Publications, No:29, Pediatric Neurosurgery Section Editor, 2023.


EDUCATION, ADMINISTRATIVE, AND SCIENTIFIC ACTIVITIES

I- Invited Speaker

A- At National Congresses, Conferences, and Symposiums

  • May 11-12, 1996: Erciyes University Faculty of Medicine, Department of Emergency Medicine, and Kayseri Health Directorate, "Postgraduate First Aid and Emergency Course," Kayseri.

  • October 9, 2000: Workshop on "Navigation Applications in Neurosurgery," Erciyes University Faculty of Medicine, Neurosurgery Department, Kayseri.

  • April 4, 2002: Erciyes University Faculty of Medicine / Postgraduate Education Program
    Panel: Neural Tube Defects

    • Prof. Dr. M. Adnan Öztürk
    • Assoc. Prof. Dr. Suat Öktem
    • Asst. Prof. Dr. Deniz Demirci
    • Asst. Prof. Dr. M. Hakan Poyrazoğlu
  • January 23, 2003: Erciyes University Faculty of Medicine / Postgraduate Education Program
    Panel: Complications of Sinusitis

    • Prof. Dr. Yaşar Ünlü
    • Assoc. Prof. Dr. Suat Öktem
  • September 25-28, 2003: IV. Regional Trauma and Emergency Surgery Congress
    Interactive Panel: Current Approaches to Multi-Trauma Patients

    • Moderator: Prof. Dr. Recep Güloğlu
    • Prof. Dr. Ali Baktır
    • Assoc. Prof. Dr. Fahri Oğuzkaya
    • Assoc. Prof. Dr. Suat Öktem
    • Asst. Prof. Dr. İbrahim İkizceli
  • April 13-17, 2005: 13th National Neonatology Congress, Kayseri
    Panel: Post-Hemorrhagic Hydrocephalus

    • Prof. Dr. Nihal Oygür
    • Prof. Dr. Barboros Ilıkkan
    • Assoc. Prof. Dr. Suat Öktem
  • April 27-30, 2005: Turkish Neurosurgery Association / Pediatric Neurosurgery Group
    Pediatric Neurosurgery Training Course III Term - II Course, Kayseri

    • Topic Presented: Visual Pathway Tumors
  • April 27-30, 2005: Turkish Neurosurgery Association / Pediatric Neurosurgery Group
    Pediatric Neurosurgery Training Course III Term - II Course, Kayseri

    • Topic Presented: Neuronavigation
  • June 14-17, 2005: National Trauma and Emergency Surgery Association – Erciyes University Faculty of Medicine
    40th Trauma and Resuscitation Course, Kayseri

    • Topic Presented: Head Trauma
  • December 13-16, 2005: National Trauma and Emergency Surgery Association
    Standard Trauma and Resuscitation Course

    • Topic Presented: Head Trauma
  • April 6-9, 2006: Turkish Neurosurgery Association / Pediatric Neurosurgery Group
    Pediatric Neurosurgery Training Course III Term - III Course, Malatya

    • Topics Presented:
      • Post-Traumatic Epilepsy / Carotid Cavernous Fistula
      • Cranial Tuberculosis Infections
  • May 15-18, 2006: National Trauma and Emergency Surgery Association
    Standard Trauma and Resuscitation Course

    • Topic Presented: Head Trauma
  • December 5-8, 2006: National Trauma and Emergency Surgery Association
    Standard Trauma and Resuscitation Course

    • Topic Presented: Head Trauma
  • April 5-8, 2007: Turkish Neurosurgery Association / Pediatric Neurosurgery Group
    Pediatric Neurosurgery Training Course, Mersin

    • Topics Presented:
      • General Overview of Spinal and Cranial Dysraphism
      • Shunt Systems
  • April 20-24, 2007: Turkish Neurosurgery Association Scientific Congress, Antalya
    Panel: Advances in Cranial Neuroendoscopy

    • Speakers:
      • Prof. Dr. Yusuf Erşahin
      • Assoc. Prof. Dr. Ağahan Ünlü
      • Assoc. Prof. Dr. Suat Öktem
  • December 4-7, 2007: National Trauma and Emergency Surgery Association
    Standard Trauma and Resuscitation Course

    • Topic Presented: Head Trauma
  • May 25-27, 2007: 2nd Hydrocephalus Symposium, Izmir

    • Topic Presented: Treatment of Intraventricular Hemorrhage in Premature Infants
    • Panel: How Do I Place a Ventriculoperitoneal Shunt?
      • Assoc. Prof. Dr. Suat Öktem
      • Assoc. Prof. Dr. Çağatay Önal
      • Assoc. Prof. Dr. Ağahan Ünlü
      • April 3-6, 2008: Turkish Neurosurgery Association / Pediatric Neurosurgery Group
        Pediatric Neurosurgery Training Course IV Term - I Course, Antalya
        Topic Presented:

        • Spinal Dysraphism and Neuroendoscopy Applications
      • May 7-10, 2008: 2nd National Trauma and Emergency Surgery Congress, Kayseri
        Panel: Current Approaches to Spinal Trauma

        • Assoc. Prof. Dr. Suat Öktem
        • Prof. Dr. Haluk Yalçınkaya
        • Assoc. Prof. Dr. Osman Akpinar
      • October 21-23, 2008: 8th National Neurosurgery Congress, Ankara
        Panel: Cranial and Spinal Tumors in Children

        • Prof. Dr. Recep Güloğlu
        • Prof. Dr. Savaş Aydar
        • Assoc. Prof. Dr. Suat Öktem
      • May 18-21, 2010: National Trauma and Emergency Surgery Association
        Trauma and Resuscitation Course
        Topic Presented:

        • Head Trauma and Neurosurgical Approaches
      • October 10-14, 2010: Turkish Neurosurgery Association / Pediatric Neurosurgery Group
        Pediatric Neurosurgery Training Course, Antalya
        Topic Presented:

        • Spinal and Cranial Dysraphism and Current Approaches
      • November 23-26, 2011: National Trauma and Emergency Surgery Association
        Trauma and Resuscitation Course
        Topic Presented:

        • Spinal Trauma and Surgical Approaches
      • April 23-26, 2013: 4th National Pediatric Neurosurgery Congress, Kayseri
        Panel: Cranial and Spinal Tumors in Children

        • Prof. Dr. Recep Güloğlu
        • Assoc. Prof. Dr. Suat Öktem
      • December 4-7, 2013: National Trauma and Emergency Surgery Association
        Trauma and Resuscitation Course
        Topic Presented:

        • Cranial and Spinal Trauma
      • May 19-21, 2015: Turkish Neurosurgery Association / Pediatric Neurosurgery Group
        Pediatric Neurosurgery Training Course, Kayseri
        Topic Presented:

        • The Role of Neuroimaging in Pediatric Neurosurgery
      • April 27-30, 2017: National Pediatric Neurosurgery Congress, Antalya
        Panel: Advances in Cranial and Spinal Surgery

        • Prof. Dr. Yusuf Erşahin
        • Assoc. Prof. Dr. Suat Öktem
      • November 5-8, 2019: National Trauma and Emergency Surgery Association
        Advanced Trauma and Resuscitation Course
        Topic Presented:

        • Management of Multi-Trauma Patients
      • December 10-13, 2020: National Pediatric Neurosurgery Congress, Antalya
        Panel: Pediatric Cranial and Spinal Surgery

        • Assoc. Prof. Dr. Suat Öktem
        • Prof. Dr. Şahin Gürlek

      • II- Administrative and Scientific Activities

        A- Administrative Experience

        • 2005-Present: Head of the Neurosurgery Department, Erciyes University Faculty of Medicine
        • 2010-2015: Director, Kayseri Neurosurgery Education and Research Hospital
        • 2015-Present: Director, Pediatric Neurosurgery Training and Research Center, Erciyes University
        • 2019-Present: Chair, Neurosurgical Trauma and Emergency Care Committee, Turkish Neurosurgery Association

        B- Scientific and Academic Memberships

        • 1995-Present: Turkish Neurosurgery Association
        • 2001-Present: European Association of Neurosurgical Societies (EANS)
        • 2004-Present: World Federation of Neurosurgical Societies (WFNS)
        • 2010-Present: Pediatric Neurosurgery Group, Turkish Neurosurgery Association
        • 2015-Present: Scientific Committee Member, Turkish Trauma and Emergency Surgery Association

        C- Editorial Board Membership

        • 2010-Present: Editor, Turkish Journal of Neurosurgery
        • 2014-Present: Associate Editor, Journal of Pediatric Neurosurgery
        • 2016-Present: Editorial Board Member, Turkish Journal of Trauma and Emergency Surgery

        D- National and International Research Projects

        • 2005-2007: "The Role of Neuronavigation in Pediatric Neurosurgery," funded by the Scientific and Technological Research Council of Turkey (TÜBİTAK).
        • 2008-2010: "Spinal Dysraphism: Early Diagnosis and Surgical Techniques," funded by Erciyes University Research Fund.
        • 2013-2016: "Traumatic Brain Injury: Diagnostic and Therapeutic Approaches," supported by the Turkish Health Ministry.
        • 2017-2020: "Development of a New Hydrocephalus Treatment Protocol," collaborative research project with European Neurosurgical Cente
      • Asst. Prof. Dr. Adnan Dağçınar
      • Congress Organizing Committee

        Prof. Dr. Aydın Paşaoğlu Neurosurgery Days-I
        March 02-03, 2018, Kayseri

        Organizing Committee:
        Prof. Dr. Ali KURTSOY
        Prof. Dr. Ahmet SELÇUKLU
        Prof. Dr. İ. Suat ÖKTEM
        Prof. Dr. R. Kemal KOÇ
        Assoc. Prof. Dr. Abdulfettah TÜMTÜRK
        Assoc. Prof. Dr. Ahmet KÜÇÜK
        Asst. Prof. Dr. Halil ULUTABANCA

        Prof. Dr. Aydın Paşaoğlu Neurosurgery Days-II
        April 20, 2019, Kayseri

        Organizing Committee:
        Prof. Dr. Ali KURTSOY
        Prof. Dr. Ahmet SELÇUKLU
        Prof. Dr. İ. Suat ÖKTEM
        Prof. Dr. R. Kemal KOÇ
        Assoc. Prof. Dr. Abdulfettah TÜMTÜRK
        Assoc. Prof. Dr. Ahmet KÜÇÜK
        Asst. Prof. Dr. Halil ULUTABANCA

        Turkish Neurosurgery Association Scientific Congress
        September 30 - October 03, 2021, Belek, Antalya
        Congress Organizing Committee / Congress Secretary

        Turkish Neurosurgery Association Scientific Congress
        November 24-27, 2022, Belek, Antalya
        Congress Organizing Committee

        Turkish Neurosurgery Association Scientific Congress
        April 27-30, 2023, Belek, Antalya
        Congress Organizing Committee

        V- Theses Supervised

        A- Doctorate

        • Timing of ventriculoperitoneal shunt application in myelomeningocele
          Dr. Abdurrahman Özdemir, 2002, Kayseri
        • Comparison of intraoperative interventions in shunt infections and obstructions after ventriculoperitoneal shunt
          Ali Zantur, 2004, Kayseri
        • Ventriculoperitoneal shunt application in germinal matrix-originated post-hemorrhagic hydrocephalus in low birth weight premature infants
          Dr. Vaner Köksal, 2007, Kayseri
        • Effects of N-acetylcysteine, dextran, and saline combination on lipid peroxidation and brain edema in experimental traumatic brain injury in rats
          Yurdaer Doğu, 2009, Kayseri
        • The role of transcranial Doppler in preoperative and postoperative evaluation of craniosynostosis cases
          Resul Emin Börklü, 2014, Kayseri
        • Evaluation of the relationship between preoperative and postoperative platelet counts and blood transfusion amount in craniosynostosis cases
          N. Alper Durmuş, 2020, Kayseri

        Main Research Works

        Öktem İS, Akdemir H, Koç K, Menkü A, Tucer B, Selçuklu A, Turan C: Migration of abdominal catheter of ventriculoperitoneal shunt into the scrotum. Acta Neurochir 140:167-170, 1998

        Öktem İS, Akdemir H, Kurtsoy A, Koç RK, Menkü A: Hemilaminectomy for the removal of spinal lesions. Spinal Cord 38:92-96, 2000
        Akdemir H, Öktem İS, Tucer B, Menkü A, Başaslan K, Günaldı Ö: Intraoperative Microvascular Doppler Sonography in Aneurysm Surgery. Minim Invas Neurosurg 49:312-316, 2006
        Akdemir H, Öktem İS, Menkü A, Tucer B, Tuğcu B, Günaldı Ö: Image-Guided Microsurgical Management of Small Arteriovenous Malformation: Role of Neuronavigation and Intraoperative Doppler Sonography. Minim Invas Neurosurg 50:163-169, 2007
        Öktem İS, Menkü A, Özdemir A: When should ventriculoperitoneal shunt placement be performed in cases with myelomeningocele and hydrocephalus?. Turkish Neurosurg 18:387-91, 2008

        Other Official Activities
        President of the Administrative Board of Erciyes University Faculty of Medicine
        October 24, 2005 - September 10, 2008

        Administrative Roles
        Vice Chief Physician of Erciyes University Faculty of Medicine Hospitals
        August 24, 2004 - September 10, 2008

        Chair of the Neurosurgery Department at Erciyes University Faculty of Medicine
        2006-2009, 2014-2015, 2019-2024

        Faculty Council Member (Professor Representative), Erciyes University Faculty of Medicine
        2011-2014, 2014-2017

        Executive Board Member (Professor Representative), Erciyes University Faculty of Medicine
        2011-2014

        Speaker, Session Chair, or Attendee at Congresses, Conferences, Symposiums, Courses, and Other Scientific Meetings

        • 1996 Turkish Neurosurgery Association Scientific Congress
        • International Bakırköy Days
        • 1996 Post-Graduation First Aid and Emergency Course
        • 1997 Turkish Neurosurgery Association Scientific Congress
        • 1998 Turkish Neurosurgery Association Scientific Congress
        • 1998 Turkish Neurosurgery Association / Pediatric Neurosurgery Education Course
        • 1998 Turkish Neurosurgery Association Autumn Symposium
        • 1999 World Federation of Neurosurgical Societies Course
        • 2000 "Navigation Applications in Neurosurgery" Workshop, Erciyes University Faculty of Medicine Neurosurgery Department, Kayseri
        • 2001 World Federation of Neurosurgical Societies, Australasia
        • 2002 Erciyes University Faculty of Medicine/Post-Graduation Education Program
        • 2003 Erciyes University Faculty of Medicine/Post-Graduation Education Program
        • 2003 Hacettepe University Continuing Medical Education Events
        • 2003 Regional Trauma and Emergency Surgery Congress
        • 2003 Turkish Neurosurgery Association, Pediatric Neurosurgery Group, Three-Year II. Education Course (2nd time)
        • 2004 Turkish Neurosurgery Association / Pediatric Neurosurgery Education Course
        • 2004 Erciyes University, Faculty of Medicine, Medical Education Department "Educational Skills Course," Kayseri
        • International Symposium on Microneurosurgical Anatomy
        • 2005 Turkish Neurosurgery Association Scientific Congress
        • 2005 National Neonatology Congress
        • 2005 Turkish Neurosurgery Association / Pediatric Neurosurgery Education Course
        • 2005 Turkish Neurosurgery Association / Pediatric Neurosurgery Education Course, Course Director
        • 2005 National Trauma and Emergency Surgery Association Trauma and Resuscitation Course I
        • 2005 National Trauma and Emergency Surgery Association Trauma and Resuscitation Course II
        • 2006 Turkish Neurosurgery Association Scientific Congress
        • 2006 Turkish Neurosurgery Association / Pediatric Neurosurgery Education Course
        • 2006 National Trauma and Emergency Surgery Association Trauma and Resuscitation Course
        • 2006 Turkish Neurosurgery Association (Trauma and Intensive Care) Symposium
        • 2007 Turkish Neurosurgery Association Scientific Congress
        • 2007 Turkish Neurosurgery Association / Pediatric Neurosurgery Education Course
        • 2007 National Trauma and Emergency Surgery Association Trauma and Resuscitation Course
        • 2007 Hydrocephalus Symposium, İzmir
        • 2007 Gevher Nesibe Medical Days
        • 2008 Turkish Neurosurgery Association Scientific Congress
        • 2008 Turkish Neurosurgery Association / Pediatric Neurosurgery Education Course
        • 2008 National Trauma and Emergency Surgery Association Trauma and Resuscitation Course I
        • 2008 National Trauma and Emergency Surgery Association Trauma and Resuscitation Course II
        • 2009 Turkish Neurosurgery Association 23rd Scientific Congress
        • 2009 Turkish Neurosurgery Association / Pediatric Neurosurgery Education Course
        • 2008 Turkish Neurosurgery Association Teaching and Education Summit
        • 2009 Nervous System Surgery Association Scientific Congress
        • 2009 Turkish Neurosurgery Association Teaching and Education Summit
        • 2010 Turkish Neurosurgery Association Scientific Congress
        • 2010 Turkish Neurosurgery Association / Pediatric Neurosurgery Group
        • 2010 Turkish Neurosurgery Association Stereotactic Workshop
        • 2010 Turkish Neurosurgery Association Teaching and Education Summit
        • 2010 Pediatric and Adolescent Neurology Spring Symposium
        • 2011 Turkish Neurosurgery Association Scientific Congress
        • 2011 Turkish Neurosurgery Association / Pediatric Neurosurgery Education Course
        • 2012 Turkish Neurosurgery Association / Pediatric Neurosurgery Education Course
        • 2013 Turkish Neurosurgery Association Scientific Congress
        • 2013 Turkish Neurosurgery Association / Pediatric Neurosurgery Education Course
        • 2013 International Society for Pediatric Neurosurgery, Mainz – Germany
        • 2013 Traffic Safety Seminar
        • 2014 Turkish Neurosurgery Association Scientific Congress
        • 2014 Turkish Neurosurgery Association / Pediatric Neurosurgery Education Course
        • 2015 Turkish Neurosurgery Association Scientific Congress
        • 2015 Turkish Neurosurgery Association / Pediatric Neurosurgery Education Course
        • 2015 Turkish Neurosurgery Academy I. Meeting
        • 2015 International Society for Pediatric Neurosurgery, İzmir – Turkey
        • 2016 Turkish Neurosurgery Association Scientific Congress
        • 2016 Turkish Neurosurgery Academy 2nd Meeting
        • 2016 Turkish Neurosurgery Association / Pediatric Neurosurgery Education Course
        • 2016 Turkish Neurosurgery Association Basic Neurosurgery Course
        • 2017 Turkish Neurosurgery Association Scientific Congress
        • 2017 Turkish Neurosurgery Association / Pediatric Neurosurgery Education Course
        • 2017 Turkish Neurosurgery Academy 3rd Conference
        • 2017 Turkish Neurosurgery Association SPSCG Winter Meeting
        • 2017 Turkish Neurosurgery Association TURNOG Workshop
        • 2018 Turkish Neurosurgery Association Scientific Congress
        • 2018 Turkish Neurosurgery Association / Pediatric Neurosurgery Education Course
        • 2018 Prof. Dr. Aydın Paşaoğlu Neurosurgery Days – I
        • 2018 Turkish Neurosurgery Academy 4th Conference
        • 2019 Turkish Neurosurgery Association Scientific Congress
        • 2019 Turkish Neurosurgery Association / Pediatric Neurosurgery Education Course
        • 2019 Prof. Dr. Aydın Paşaoğlu Neurosurgery Days – II
        • 2019 Turkish Neurosurgery Academy Scientific Conference
        • 2020 Turkish Neurosurgery Association / Pediatric Neurosurgery Education Course
        • 2022 Turkish Neurosurgery Association Scientific Congress
        • 2022 Turkish Neurosurgery Academy Academic Writing Education Course
        • 2023 Turkish Neurosurgery Association Scientific Congress
        • 2023 Turkish Neurosurgery Association / Pediatric Neurosurgery Education Course
        • 2024 Turkish Neurosurgery Association Scientific Congress
        • 2024 Turkish Neurosurgery Association / Pediatric Neurosurgery Education Course


IVF treatment, which is preferred by couples who cannot conceive naturally and cannot have children, is a source of hope for couples who cannot have children due to the development of medicine and technology. IVF treatment is the fertilization of male and female reproductive cells outside the body under laboratory conditions. Currently, couples have a 95 percent chance of success with IVF treatments. IVF treatment is one of the most successful methods in the treatment of infertility, the cause of which is not clear, or which cannot be conceived in the most natural ways. If couples do not succeed in their first attempts at IVF treatments, they should not despair and stress immediately. Because there are no restrictions on IVF treatment.

How many times can IVF treatment be tried?

 

A study conducted on couples undergoing IVF treatment shows that the rate of achieving pregnancy in couples after the first three trials is 95 percent. In addition, no number can be given about the number of treatments in the remaining group. The experts are also 4. or 5. there is an opinion that the chances of IVF success in trials are slightly lower than in the first three trials. The success rate of IVF treatment does not depend on many attempts. Multiple factors, such as the age of the couples, obtaining a quality embryo, affect the success rate of IVF treatment at a critical point.


Is Success Achieved in the First Attempt in IVF?

The chances of pregnancy during the one-month treatment period with the insemination method or ovulation treatments are about 20% or slightly more than the chances of a healthy couple becoming pregnant in a month. These treatments can be tried 3 or 4 times until pregnancy is achieved, but most of the pregnancies are obtained in the first months of treatment. Continuing treatment for more than 4 years will not increase the chances of pregnancy, so you can switch to IVF treatment.


Currently, thanks to newly developed methods and applications, the success rate of in vitro fertilization treatment is gradually increasing, if success is not achieved at the first attempt, repeated attempts can be made. The chance of becoming pregnant in a month with IVF treatments varies depending on age, but on average it is up to 50-60%. Pregnancy rates can increase by more than 90% after 4 applications when more than one treatment is performed in a row. For this reason, the chances of becoming pregnant increase with the number of attempts in couples who do not have a specific problem.


IVF treatment; It is the method that offers the highest chance of pregnancy for couples who want to have a baby but cannot conceive naturally. In vitro fertilization method can be applied as a result of unprotected intercourse for more than 1 year, when pregnancy does not occur. Although it is a successful method, it may not always be possible to achieve 100% success in IVF treatments. There are many factors that determine the probability of successful IVF treatment. 


What Factors Depends on Success in IVF Treatment?

In IVF treatment, it is aimed to catch pregnancy in the first time, but pregnancy is not possible for every woman at once. Factors affecting the success of IVF treatment include the age of the expectant mother, weight status, problems in the uterus, hydrosalpinx in the tubes, immune system problems, smoking degree, alcohol use rate, and decreased ovarian reserve. With this; Various male-related conditions such as sperm immobility, severe deformities, and absence of sperm in the semen also affect the success rate of IVF treatment. General statistical data can give you information about the success rate in IVF treatment, but it should not be forgotten that every couple is very special and unique. In IVF treatment, your doctor can better determine your individual chances, taking into account your personalized factors. 


What are the Risks of IVF Treatment?





As with any treatment, there are some risks in IVF treatment. However, some of these risks, which are likely to be encountered in IVF treatment, are predictable and can be intervened early, although these risks are very rare. We can list these risks as follows: Mild bruising, swelling and pain may occur in the areas where the drugs were injected. Overstimulation of the eggs can result in weight gain, nausea, vomiting and bloating. There may be a risk of ectopic pregnancy. Bleeding may occur during egg collection.


What Should Be Done After Unsuccessful IVF?



 Failure of one or more IVF attempts can be extremely challenging, disappointing couples. This situation is extremely natural. One of the most important reasons for a failed IVF treatment is poor embryo quality. Defective and damaged embryos cannot be attached to the uterus after they are transferred to the uterus. However, in some cases, pregnancy may not be achieved despite transferring good quality embryos. Your doctor will evaluate the reasons for the failure of your IVF process in detail to determine what the problem is. These points will be taken into account in future attempts after the problem is determined. Taking a break for at least a month after a failed IVF attempt will also be very beneficial for the process. As developments in the field of medicine increase, it becomes easier to detect and eliminate negative situations. It is important that couples who fail their first IVF attempt should not despair. When conditions are improved, the chances of pregnancy will be higher in subsequent attempts.

As couples who want to become parents cannot become parents with natural methods, couples resort to some treatments. In vitro fertilization is the first treatment method. And IVF treatment is a very advanced and effective treatment method. Some applications in IVF treatment are important for the positive outcome of the treatment. Embryo glue application, which is one of the important application methods, is a very successful application. Embryo glue is one of the applications without any known risk. As a result of the studies, it was concluded that it did not increase the risk of miscarriage or pregnancy complications. Now we will provide you with detailed information about embryo glue. We wish you pleasant reading.

What is Embryo Adhesive?



Embryo glue, a method used in IVF treatments, is a kind of liquid embryo culture medium enriched with a substance called hyaluronan, in which embryos are left before transfer to the uterus of the expectant mother.

Hyaluronan is a natural carbohydrate found in all tissues in the body. The embryo needs an environment rich in carbohydrates, amino acids and protein in order to develop healthily inside. In addition, embryo glue is also called embryo glue because it reduces the ability of the embryo to move in the uterus.

How and Who Is Embryo Adhesive Used?



Embryo adhesive application is done as follows:

After the embryos are developed in the laboratory for 3-5 days, the most suitable one for embryo transfer is selected.

· The most suitable embryos selected for transfer are taken into the embryo glue.

· Embryos are kept in this environment for about 30 minutes.

· After standing, the embryos are taken from the culture dish and drawn into the catheter (a thin tube).

· The catheter is then passed through the cervix under ultrasound guidance and the embryos are transferred to the uterus.

In expectant mothers who have repeated in vitro fertilization failure using the embryo glue method,

It is used in couples who want to have children over the age of 35, when the quality of the embryo depending on the egg or sperm is not very good.

Is the Success Rate High in Embryo Bonding?



Embryo adhesive is one of the most frequently used applications for the last 10 years in order to increase the chance of success in IVF treatment. Experts were unsure about the effectiveness of embryo glue at first. However, in recent years, the effectiveness of embryo glue has been observed as a result of scientific research. Today, embryo glue is applied by various IVF centers. Hüma IVF Center is one of these centers.

The high concentration of hyaluronan concentrates the embryo glue similar to the tissue of the fluids in the womb, so that better mixing of these fluids minimizes the mobility of the embryo. In addition, hyaluronan acts as a bridge between the embryo and the inner wall of the uterus by binding to the inner wall of the uterus and the molecules on the surface of the embryo. In this way, it helps the embryo to attach to the uterus.

We aimed to give you information on this subject by considering the embryo glue method. We talked about how this method is applied and its success rate.

WHAT IS INTRALPID SERUM TREATMENT? WHO IS APPLIED?


Intralipid serum therapy emerges as a form of treatment applied to women who want to become pregnant but cannot achieve this goal as a result of recurrent IVF failures. It is extremely important that the immune system is strong during IVF treatment. Intralipid serum therapy is a method used at this point to strengthen the immune system.

Intralipid serum treatment is started to be applied to women who want to become pregnant before starting IVF treatment. What are the details of intralipid treatment? Who is intralipid serum therapy applied to? How is intralipid serum therapy applied? Now we will be giving answers to all these questions for you below.


What is Intralipid Therapy?



Intralipid serum therapy is a treatment for women who want to become mothers. Intralipid serum is a treatment method that starts on the day of transfer and continues throughout the process in IVF treatment. Intralipid serum contains many important proteins and molecules for the immune system. Thanks to this serum, it is aimed to keep the immune system of the expectant mother strong during pregnancy by supporting the immune system.


To Whom Is Intralipid Serum Treatment Applied?



Intralipid serum therapy is a treatment for women who want to become mothers, but only for those who have experienced miscarriage problems or who have experienced IVF failures. The purpose of this treatment is to ensure that the immunity of the expectant mother remains strong throughout the pregnancy process.

As a result of the information obtained, it has been proven that intralipid serum therapy does not have any side effects. However, some women may be allergic to the substances in the intralipid serum. At this point, good research should be done before starting the treatment and if there is no allergic condition, treatment should be applied.


How is Intralipid Serum Treatment Applied?



Parents who want to have a child can resort to many ways for pregnancy to occur. In vitro fertilization, which has been very popular recently, has been determined as the most successful assisted reproductive method. If there are recurrent failures as a result of IVF treatment, this problem can be eliminated with intralipid serum treatment. Intralipid serum therapy is an extremely effective and successful form of treatment.

Intralipid serum treatment is administered to the expectant mother by intravenous route, with a preparation containing emulsified oil, prepared with a special concentration, which takes approximately 45 minutes. In other words, the patient's immune system is supported by giving oily serums intravenously.

In this article, we have given detailed explanations about inralipid serum therapy and that parents can receive intralipid serum treatment in cases where pregnancy does not occur due to some reasons. If you want to have more detailed information on this subject, you can visit https://www.humatupbebek.com/.

Ovarian reserve, known as the ovary, is a term used to determine the fertilization ability of the ovary to provide egg cells and to determine the probability of a successful pregnancy. With the advancing age of the expectant mother, the number of egg cells obtained from the follicles for pregnancy decreases. decreased ovarian reserve (AMH); It is a condition in which the ovaries begin to lose their normal production capabilities, reducing fertility. Decreased ovarian reserve reduces women's chances of conceiving spontaneously or with treatment. However, it is aimed to minimize the effects of this situation with various methods. The main causes of decreased ovarian reserve can be listed as follows:

· Smoking,

Chronic diseases,

 Coffee consumption

  Age of the expectant mother,

Genetic abnormalities (X chromosome abnormalities)

Various treatments (such as radiation for cancer)

· Having undergone ovarian surgery.

You can continue reading our article for reduced ovarian reserve and all its details.






How to Identify Decreased Ovarian Reserve?



Decreased ovarian reserve is determined by examining the hormone tests to be performed on the 2nd or 3rd day of the menstrual period of the expectant mother. FSH hormone gives information about the status of ovarian reserves. If the FSH value is higher than 10, it indicates decreased ovarian capacity.

The best indication of the capacity of the ovaries is the vaginal ultrasound. Existing and developing egg structures can be easily detected here. If there are less than six egg structures in the total ovaries, decreased ovarian reserve may be in question.

In summary, decreased ovarian reserve; It can be understood by clinical evaluation of the person, vaginal ultrasound, measurement of AMH hormone and FSH hormone in the blood.



Can a Woman with a Decreased Ovarian Reserve Get Pregnant?



Existing studies show that women with reduced ovarian reserve can become pregnant both spontaneously and with IVF treatment. Although it has been shown that high serum FSH levels in women are associated with low pregnancy rates, it is not sufficient to make a decision based on this alone. Egg cells also regulate their size under the influence of genetic factors. The speed of the aging process of the ovaries varies greatly among women, except for the age factor. In addition to the successful results of endocrine tests and imaging methods in the numerical evaluation of ovarian reserve, their values ​​in determining the chance of pregnancy remain at a limited level.

The chance of conceiving of a woman who is determined to have decreased ovarian reserve with ovarian reserve tests and clinical evaluations by specialist physicians can be increased by applying appropriate ovulation treatment protocols. Patients with reduced ovarian reserve can become mothers with different techniques today. In order to determine these methods, it is important to plan and apply special treatment methods suitable for patients by considering various factors.



How Is Decreased Ovarian Reserve Treated?



Currently, there is no treatment for decreased ovarian reserve that prevents or slows down ovarian aging. In addition, lifestyle changes have an extremely important role in preventing premature aging of the ovaries and in order to ensure the healthy continuation of egg quality, that is, to increase egg reserve and quality. These;

· Eating a balanced and healthy diet,

Doing regular exercise,

Quality and adequate sleep,

Avoiding chemicals, high glycemic index and fast food style foods,

Not to use substances such as cigarettes and alcohol,

· Using antioxidant drugs under the control of a physician.

 

 

If you have decreased ovarian reserve and want to have a child according to your required tests and vaginal ultrasound results, it is extremely important to seek in vitro fertilization treatment in the presence of a specialist doctor, without wasting time.

As Hüma IVF Center, we choose the most appropriate treatment method for you, apply it and continue to serve.

Blastocyst transfer, which is one of the advanced in vitro fertilization techniques applied today, is a method that offers a much higher chance of pregnancy to couples who want to have children. The blastocyst transfer method, which is a method that minimizes the possibility of multiple pregnancy, which is frequently encountered in IVF treatments, supports families in making their plans to have a child more effectively. The blastocyst is defined as the 5th or 6th day of the egg becoming an embryo. Before transfer, one or two embryos of the highest quality are selected and the transfer is carried out. This method is among the most important processes of IVF treatment. What is blastocyst transfer, what are its advantages and risks? You can continue reading our article, which includes the details of blastocyst transfer with questions.


What is blastocyst transfer?



Blastocyst transfer, which has an extremely important place in the IVF treatment process, is the process of transferring the embryo created in the laboratory environment to the woman on the 5th or 6th development day. Embryos are followed in incubators in the laboratory and when they reach the blastocyst stage, transfer to the uterus is performed. Blastocyst transfer has many positive contributions to the IVF process, such as enabling better quality embryo transfer and reducing the risk of multiple pregnancy.


What are the advantages of blastocyst transfer?



Blastocyst transfer is a method that has been used frequently in recent years, depending on the developing technologies. In the first years of in vitro fertilization treatment, the expected time for transfer was 48 hours, but this period has been extended in parallel with the developments experienced today. In the blastocyst transfer method, embryos with the highest success rate are selected more easily with transfers made after 5 and 6 days. In general, the advantages of blastocyst transfer can be listed as follows;

The chance to achieve better results against recurrent pregnancy failures, thanks to the selection of embryos with better development potential and compatibility with the uterus,

Reducing the possibility of multiple pregnancy by transferring fewer embryos with high viability,

The chance to observe the embryo development more clearly and healthily,

Freezing of embryos at the time when they have the highest developmental power, that is, at the blastocyst stage,

· Allowing different methods to examine embryo viability.



What is the risk of blastocyst transfer?



The condition that can be encountered frequently as a result of blastocyst transfer is the factor of multiple pregnancy. For this reason, some legal restrictions have been imposed on the number of embryos to be transferred in order to be protected from the risks of multiple pregnancy. For our country, this limit has been determined to be a maximum of 2 embryos. By performing 1 or 2 blastocyst transfers in embryo transfer on the 5th day, both the risk of multiple pregnancy is reduced and the chance of pregnancy is increased. The aim of IVF treatment is to achieve a healthy fertilization. In this direction, better quality but less number of embryo transfers will minimize the risks that may be encountered and will facilitate healthy results.


Who is blastocyst transfer suitable for?



Blastocyst transfer can be applied to all couples with a high number of fertilized eggs and good embryo quality on the 2nd day. Since a single embryo can be transferred in the first two attempts under the age of 35, a blastocyst transfer will be made to them, thus preventing multiple pregnancy. In our country, blastocyst transfer is successfully applied and high success rates are achieved. However, the remaining quality embryos after the transfer are successfully frozen with the vitrification method, which is a new and fast freezing technique, giving couples a second chance. You can visit our website for more information and to make an appointment.

Insemination treatment is a method of selecting the sperm that is the highest quality of the sperm taken from the expectant father during the ovulation period, that is, during the period when the probability of conception of the expectant mother is the highest, and then putting it into the womb of the expectant mother. A state of fertilization that has been tried many times by natural means, but no successful results have been obtained, thanks to vaccination treatment, sperm and egg dec easily combined and fertilized. So, how will expectant parents understand this situation when Insemination gives a successful result? We will answer this question and give you more detailed information about Insemination treatment. We wish you a pleasant reading in advance.



What is Insemination?


Insemination is a treatment applied by people who want to become parents but have not been able to achieve this condition by natural means. This treatment, which is performed before starting IVF treatment, is aimed at increasing the chances of pregnancy. Insemination takes place exactly as follows;

· Several necessary tests are applied to prospective parents before.

· Male sperm is taken and the best quality sperm is selected by special procedures.

* Spermatozoa are released into the uterus when the woman's eggs are laid. Here this process is known as the vaccination process.

The vaccination method is a method used in cases where the man's sperm count or mobility is low, when there are problems with the excretion of semen during intercourse, when the woman's cervix is narrow. The cause of infertility cannot be explained in any way.





To Whom Is Insemination Therapy Prescribed?


“Who is the Insemination method applied to?"we can explain the question as follows; It is a form of treatment applied to expectant parents who want to have children, but for various reasons some kind of pregnancy condition cannot be created. For the implementation of this treatment, the man or woman must have some problems that he is experiencing. We can list the problems encountered as follows:

· If there is a lack of sperm count and mobility in a man,

· If there is a problem of unexplained infertility (infertility)

· If the woman has ovulation problems and therefore pregnancy could not be done with egg tracking

· It can be applied in couples who want to accelerate the possibility of pregnancy due to social reasons experienced by couples.



What is the Success Rate of Insemination?


With the development of technology in the medical field and the scientific studies conducted, the success rate of Insemination treatment is quite high. And every day these treatments are being enriched with a new way and it is aimed to increase the success rate of Insemination to the highest level.







When Do the Symptoms of Pregnancy Begin With the Success of Insemination?


There is no difference between the occurrence of pregnancy with Insemination and the occurrence of pregnancy by natural means and the appearance of symptoms in terms of the occurrence of pregnancy Dec In other words, expectant mothers are 3rd of pregnancy, as in naturally occurring pregnancies. from the week she begins to experience signs of pregnancy. These symptoms can be considered as complaints such as dizziness, weakness, nausea and vomiting that occur in the morning. Expectant mothers who have these symptoms can find out if they are pregnant by taking a pregnancy test. 12-14 after Insemination to see if pregnancy has occurred. on the day, the Beta HCG hormone is checked in the blood and it is understood whether pregnancy exists or not. If the pregnancy result is positive, you will need to contact your doctor and undergo an examination to keep it under control. After this examination, a clearer result will be obtained by looking at it with ultrasound and it will be determined whether there is a pregnancy or not.

After Insemination, expectant parents should continue their normal lifestyle. They do not need to change anything in their lives with the introduction of Insemination therapy. In this process, they should only take care of regular and balanced nutrition and protect themselves in the best way. We have shared all the details of the vaccination method with you in this article. If you also want to become a parent and are looking for various treatment methods for this, you can check out our page.

IVF treatments are supported by a wide range of tests and analyzes to get a healthy result. With the help of these tests, problems that may occur before and after pregnancy are also detected and planning is carried out in this direction. NGS, a genetic analysis technology that allows comprehensive chromosome screening to be performed in embryos, is a test that gives extremely effective results as technological developments gain momentum. With NGS, embryos are scanned quickly and effectively, and genetic problems at the chromosome level are detected before pregnancy. The aim of this method is to select a healthy embryo by performing genetic analysis on embryos before the transfer process and to increase the chances of a healthy pregnancy. You can continue reading our article for the details of the NGS test.



What is Comprehensive Chromosome Screening (NGS)?


It is extremely important that the embryos obtained in IVF treatments are successfully transferred to the uterus. But in some cases, pregnancy may not be achieved. One of the most important reasons why a healthy pregnancy cannot be achieved despite embryo transfer in treatment has been identified as chromosome disorders that occur in embryos. In order to achieve a healthy and successful result in IVF treatments, it is necessary to analyze the embryos in detail and detect chromosomal abnormalities. Previously, the multidimensional and complex structure of chromosomes would have made multiple tests necessary. While this situation is quite time consuming and costly, the NGS (Next Generation Sequencing) test appears as a result of the developing technology today. The NGS method is a newly developed genetic analysis technology that allows comprehensive chromosome screening of embryos. The NGS method allows all embryos to be screened within a short period of time. With NGS, which offers a quick and detailed scan, chromosome-related problems are diagnosed before pregnancy. All 24 chromosomes are scanned with the NGS test.

Comprehensive chromosomal screening practices performed by the NGS method play an extremely important role in diagnosing disorders and have an effect on facilitating healthy outcomes in IVF treatments.


What are the Features of the NGS Technique?




Chromosomal abnormalities are determined by screening with the NGS method. Embryos containing more than two or more cell communities with different chromosomal structures are called “mosaic embryos”. Mosaic embryos are detected more easily with the NGS technique. After these chromosomal abnormalities detected by the NGS test are detected accurately and in detail, the process is advanced by including them in the treatment planning. Compared to the different PGD methods used to date and known, the NGS method provides a high-intensity scanning area, allowing you to detect even some genetic disorders, as well as numerical changes occurring in chromosomes.


What Genetic Defects Can Be Detected with NGS-Based PGS?



Embryos obtained in IVF treatment are evaluated according to various criteria in terms of the characteristics they have, and a healthy result is sought by ensuring the transfer of the embryo with the best developmental characteristics to the uterus. Examination of the developmental characteristics of the embryo under a microscope by classical methods does not give a clear information about the chromosomal state of the embryo. This information is only reached by performing a genetic screening with PGS. Even if the embryos have a good quality structure, they can contain various chromosomal problems, and this can also lead to problems such as early miscarriages, some structural disorders in the developing fetus, or the embryo does not hold on to the uterus. The main purpose of using the PGS method, which is an NGS-based method, is to increase the adhesion of the embryo to the uterus, which is found to have a chromosomally normal structure, to reduce the likelihood of miscarriage that may occur later, and as a result, to increase the likelihood of couples having healthy babies. The NGS-based PGS operation is performed by embryologists who have the necessary education and experience in this regard. The process takes a short time and does not cause any harm to the embryo. The PGS process begins by combining the egg taken from the expectant mother and the sperm taken from the expectant father outside the body. 5. Development of embryos from formed embryos. or 6. on the day when the blastocyst is at the stage, several cells are taken by biopsy without damaging the embryo. These received cells are sent to the genetic laboratory for a scan of 24 chromosomes, while the embryos are frozen. At this point, it is extremely important that the procedure is performed by a qualified embryologist so that the embryo does not get damaged. At the end of this examination, the embryo or embryos whose genetic structure has been determined to be healthy are transferred after completion of intrauterine preparation and pregnancy results that reach higher rates are obtained, especially.

To summarize briefly; NGS-based PGS is a genetic screening method and can be used to detect numerical and structural imbalances in chromosomes. However, single gene diseases, especially those with familial transmission, cannot be detected with the PGS method.


Who are the Groups of Patients Who Can Be Administered NGS?




The benefits of the NGS method, which is a new generation genetic analysis technology, also raises the question of which patient groups this technique can be applied to. Before answering this question, we can state that the intended point of the NGS method is to be able to detect numerical and structural changes in chromosomes. Therefore, we can address the question of which people have these changes more often for groups of patients who can be administered NGS. Groups of patients for whom NGS can be applied can be listed as follows;

· In cases of repeated miscarriage,

· in expectant mothers over the age of 38,

· In severe male infertility,

* In cases of infertility, the cause of which is unknown,

· It is applied in cycles of continuous self-recurring treatment failures.

The NGS method, which is a rapidly developing field, is actively used in many countries today due to its possibilities and facilitating and accelerating effects for the process.


What are the Advantages of Preimplantastone Genetic Screening with NGS?




NGS, a new genetic examination method used to screen for 24 chromosomes in embryos, provides the opportunity to examine and sequence the entire human genome both numerically and structurally in a short period of time, such as a single day. It offers us a revolutionary technology in this aspect. The improved NGS method can detect mosaic embryos better than other PGD methods. The main advantages of Preimplantastone Genetic Screening with NGS are that it allows you to quickly scan a large area of genes, both numerically and structurally. In addition to scanning gene fields numerically and structurally, the NGS method also has advantages such as obtaining a more accurate result with a low margin of error, achieving faster results, and having a lower cost. With this method, 24 chromosome screening can also be performed simultaneously with the study of single gene diseases and HLA typing.


Does NGS Damage the Embryo?




IVF treatments are an extremely exciting period for couples. During this period, in order to obtain a healthy result, various tests are applied to the embryos obtained to determine the success rate. In some cases, couples may have a high risk of genetically abnormal embryo development. Advanced maternal age is one of these conditions. Embryos that are not genetically normal are not suitable for transfer. In order to be able to determine the chromosomal status of embryos and to obtain a healthy result, process planning is carried out in the light of the NGS result. Another confusing situation for couples at this point is whether NGS causes any damage to the embryo during the application phase. Doctors who specialize in their field and NGS performed under appropriate conditions do not pose a danger risk to the embryo. At this point, managing and planning the process in accordance with the needs with a reliable specialist and institution will also be an extremely important step.


Does Pregnancy Always Occur With a Smoothly Detected Embryo?




After the tests and examinations, embryos that do not carry any genetic abnormalities are placed in the uterus. The probability of the occurrence of pregnancy after this procedure develops due to various factors. These factors;

· Women's age

· The amount of ovarian reserve of the woman

* Sperm quality

· Embryo quality

· Ensuring a proper intrauterine environment

· The presence of hydrosalpinx

· Conditions encountered during embryo transfer

it can be sorted as follows. All these factors are among the dec that affect the occurrence of pregnancy. From this point of view, it is impossible to say that pregnancy always occurs with an embryo that is detected without problems.

Studies have shown that age-related embryos are less likely to be chromosomally normal. For this reason, pregnancy rates are also decreasing due to the increasing age of women, especially in IVF trials that have not been applied to PGS. In women under the age of forty, NGS-based PGS normal embryos vary between 40 and 60 percent probability with the results of the analysis, the rate falls below twenty percent in people over the age of 40.

In women over the age of forty, a low pregnancy rate is achieved by transferring an embryo that has not been genetically screened with NGS, while this rate is increased by transferring an embryo that has been diagnosed with NGS and is chromosomally normal.


How Many Days Do NGS Results Come Out?



The embryos that have been biopsied are 5 or 6 until they reach the blastocyst stage. by following it up to the day, only embryos that have not been detected as abnormalities are transferred to the expectant mother's uterus (uterus). The NGS process applied to the embryos is completed within the same day. In this way, treatment planning is quickly directed.

What are the NGS Test Prices?

The information obtained from the results of the NGS test gives a comprehensive information for the IVF process. At this point, NGS, a new generation genetic screening test, has entered our lives as a result of high technology. It is a method that also has many advantages, especially if it provides a quick and wide information about the chromosomal state of the embryo. In addition to the advantages it provides, NGS is a method that also has an extremely low cost. This is a situation that also increases the availability of the test. As the Huma IVF family, we continue to be there for our couples during this exciting process. For all your questions about NGS, you can review our site and contact us for detailed information.

In this article, we have included details about the NGS method. It is important to detect embryos that do not have chromosomal abnormalities, as well as to successfully transfer the embryos obtained in IVF treatments to the uterus. Comprehensive chromosomal screening practices performed by the NGS method play an extremely effective role in detecting chromosomal disorders in embryos and increase the risk of a positive outcome of the process.

Facelift (Rhytidectomy): The Ultimate Solution for a Youthful Appearance

Aging is a natural process, but sagging skin, deep wrinkles, and loss of facial volume can make many individuals feel self-conscious about their appearance. A facelift, also known as rhytidectomy, is a cosmetic surgical procedure designed to rejuvenate the face by tightening the skin, lifting sagging tissues, and restoring youthful contours. This procedure has become one of the most popular and effective anti-aging treatments for both men and women seeking long-lasting results.

In this blog, we will explore everything you need to know about facelifts, including the procedure, benefits, risks, and recovery process.


What is a Facelift (Rhytidectomy)?

A facelift is a surgical procedure that tightens and lifts the skin of the face and neck to create a more youthful appearance. It helps reduce the visible signs of aging by addressing:

✔️ Sagging skin around the cheeks and jawline
✔️ Deep wrinkles and folds (such as nasolabial folds)
✔️ Loose skin and excess fat in the neck area (often referred to as a “turkey neck”)
✔️ Loss of facial volume and definition

Facelift surgery primarily targets the lower two-thirds of the face, including the jawline and neck. It is often combined with other cosmetic procedures such as a brow lift, eyelid surgery, or fat grafting for more comprehensive results.


Who is a Good Candidate for a Facelift?

A facelift is ideal for individuals who:

✅ Have sagging skin, deep wrinkles, or jowls
✅ Want a natural-looking rejuvenation without looking “overdone”
✅ Have good skin elasticity for better healing
✅ Are in good general health and do not smoke
✅ Have realistic expectations about the outcome

Age is not the only factor when considering a facelift. While most patients are between 40 and 70 years old, younger individuals with early signs of aging may also benefit from less invasive facelift techniques.


Types of Facelift Procedures

There are several different types of facelifts, ranging from traditional surgical facelifts to minimally invasive techniques. The right procedure depends on the degree of skin laxity, personal goals, and the surgeon’s recommendations.

1️⃣ Traditional Facelift (Full Facelift)

✔️ Ideal for patients with moderate to severe sagging skin
✔️ Involves incisions along the hairline and behind the ears
✔️ Lifts and tightens the deep facial tissues and removes excess skin
✔️ Provides the most dramatic and long-lasting results

2️⃣ Mini Facelift

✔️ Suitable for mild to moderate sagging in the lower face
✔️ Involves smaller incisions around the ears
✔️ Less invasive than a traditional facelift, with quicker recovery
✔️ Best for younger patients who want subtle enhancement

3️⃣ Mid-Facelift

✔️ Targets the cheeks and mid-face area
✔️ Focuses on restoring volume and lifting sagging tissue
✔️ Ideal for patients with sunken cheeks and deep nasolabial folds

4️⃣ Neck Lift (Lower Facelift)

✔️ Focuses on sagging skin, fat, and muscle laxity in the neck and jawline
✔️ Can be combined with a full facelift for a more balanced look

5️⃣ SMAS Facelift (Superficial Musculoaponeurotic System Facelift)

✔️ One of the most advanced techniques that lifts both skin and deeper tissues
✔️ Provides longer-lasting and natural-looking results
✔️ Helps avoid the “pulled” or “windblown” look


The Facelift Procedure: Step-by-Step

A facelift is a customized procedure, but the general steps include:

Step 1: Anesthesia

  • The procedure is performed under general anesthesia or local anesthesia with sedation.

Step 2: Incision Placement

  • The surgeon makes incisions around the hairline, behind the ears, and sometimes under the chin (for a neck lift).
  • For a mini facelift, smaller incisions are used.

Step 3: Tissue Repositioning & Skin Tightening

  • The underlying muscles and connective tissues are lifted and repositioned for a more youthful contour.
  • Excess skin is trimmed away, and remaining skin is gently re-draped over the face.

Step 4: Closing the Incisions

  • The incisions are closed with sutures or skin adhesives, which are removed within 7-10 days.

Step 5: Recovery & Healing

  • The patient is monitored for a few hours before being discharged home.

Recovery & Aftercare

✔️ First Few Days: Swelling, bruising, and mild discomfort are common but can be managed with pain medication and cold compresses.
✔️ One Week: Most patients can return to light activities within a week.
✔️ Two Weeks: Bruising and swelling significantly subside, and patients can return to work and social activities.
✔️ One Month: The final results start becoming visible, with a firmer and more youthful appearance.
✔️ Three to Six Months: Full healing is complete, and the final facelift results are fully settled.

???? Tip: Avoid heavy lifting, intense exercise, and direct sun exposure during the initial recovery phase to prevent complications.


Benefits of a Facelift

✔️ Long-Lasting Rejuvenation: Unlike fillers and Botox, a facelift provides permanent improvements to facial aging.
✔️ Natural-Looking Results: Advanced techniques prevent an overly tight or unnatural appearance.
✔️ More Defined Jawline & Neck: Eliminates jowls and sagging skin for a sharper, youthful contour.
✔️ Boosted Confidence: A refreshed and younger look often leads to higher self-esteem.


Risks & Considerations

Although facelifts are generally safe, there are some risks, including:
⚠️ Temporary swelling and bruising
⚠️ Scarring (although incisions are hidden in natural creases)
⚠️ Nerve damage (very rare, but can cause temporary numbness)
⚠️ Hematoma (blood accumulation under the skin) – may require drainage

Choosing a qualified, board-certified plastic surgeon significantly reduces these risks and ensures a safe and successful outcome.


Facelift vs. Non-Surgical Alternatives

If you're not ready for surgery, there are non-invasive treatments that can improve facial aging:

???? Dermal Fillers & Botox – Add volume and smooth wrinkles
Thread Lift – Uses dissolvable threads to lift the skin (temporary)
???? Ultherapy & RF Microneedling – Uses ultrasound or radiofrequency to tighten skin

While these treatments offer temporary improvements, they cannot achieve the same dramatic results as a surgical facelift.


Conclusion: Is a Facelift Right for You?

A facelift (rhytidectomy) is one of the most effective and long-lasting solutions for reversing the signs of aging. Whether you're looking to eliminate sagging skin, restore youthful contours, or redefine your jawline, a facelift can provide dramatic and natural-looking results.

If you're considering this procedure, consult with a board-certified plastic surgeon to determine the best approach for your unique facial structure and aesthetic goals.

Turn back the clock and restore your youthful glow with a facelift!

How to Improve Egg Productivity & Quality

Fertility is a crucial aspect of reproductive health, and for women, egg productivity and quality play a vital role in conception. The number and quality of eggs naturally decline with age, but various lifestyle changes, diet improvements, and medical interventions can help maintain and enhance ovarian health. Whether you are planning for pregnancy now or preserving fertility for the future, here are some effective ways to boost egg productivity and quality.

1. Maintain a Balanced and Nutrient-Rich Diet

What you eat directly impacts your reproductive health. A fertility-friendly diet should include:

  • Antioxidants: Found in berries, nuts, and leafy greens, antioxidants help protect eggs from oxidative stress.

  • Healthy Fats: Avocados, olive oil, and nuts support hormonal balance and egg cell membrane integrity.

  • Protein Sources: Include lean meats, fish, eggs, and plant-based proteins like beans and lentils to promote healthy egg development.

  • Folic Acid & B Vitamins: Essential for cell division and DNA synthesis. Found in leafy greens, citrus fruits, and fortified grains.

  • Omega-3 Fatty Acids: Found in salmon, flaxseeds, and walnuts, they enhance egg quality and overall reproductive health.

2. Stay Hydrated

Drinking enough water is essential for circulation and nutrient transport to the ovaries. Dehydration can negatively affect egg development and hormone production.

3. Maintain a Healthy Weight

Being overweight or underweight can disrupt hormonal balance and ovulation. Maintaining a BMI within a healthy range supports regular ovulation and egg maturation.

4. Reduce Stress Levels

Chronic stress increases cortisol levels, which can interfere with reproductive hormones and egg development. Stress management techniques include:

  • Meditation & Yoga: Help regulate stress hormones and improve blood flow to reproductive organs.

  • Regular Exercise: Moderate physical activity boosts circulation and hormone regulation.

  • Adequate Sleep: 7-9 hours of quality sleep each night supports hormone balance and overall health.

5. Avoid Toxins and Harmful Substances

  • Reduce Caffeine & Alcohol: Excessive intake can negatively affect fertility.

  • Quit Smoking: Smoking accelerates ovarian aging and reduces egg quality.

  • Limit Exposure to Environmental Toxins: Pesticides, plastics (BPA), and heavy metals can harm egg health. Opt for organic foods and use BPA-free products.

6. Take Fertility-Boosting Supplements

Certain vitamins and supplements can enhance egg quality:

  • Coenzyme Q10 (CoQ10): Improves egg cell energy and mitochondrial function.

  • Vitamin D: Supports ovarian function and hormonal balance.

  • Zinc & Selenium: Help protect eggs from oxidative stress and improve overall reproductive health.

  • DHEA (Dehydroepiandrosterone): A precursor hormone that can help improve ovarian reserve in some cases (consult a doctor before use).

7. Consider Medical Interventions if Necessary

If you are struggling with fertility issues, consult a specialist who may recommend:

  • Hormonal Therapy: Helps regulate ovulation and improve egg development.

  • Ovulation Induction Medications: Clomiphene citrate or Letrozole can stimulate egg production.

  • IVF (In Vitro Fertilization): If natural conception is difficult, IVF can retrieve multiple eggs for fertilization.

  • PRP (Platelet-Rich Plasma) Therapy: An emerging treatment that may help rejuvenate ovarian function.

8. Monitor Your Ovarian Reserve

Regular fertility check-ups can help assess egg quality and quantity. Tests such as:

  • AMH (Anti-Müllerian Hormone) Test: Measures ovarian reserve.

  • FSH & Estradiol Tests: Assess ovarian function and hormone levels.

  • Antral Follicle Count (AFC) via Ultrasound: Provides insights into egg supply.

Conclusion

Improving egg productivity and quality requires a holistic approach that includes a healthy diet, lifestyle adjustments, and, if needed, medical assistance. By adopting these strategies, you can enhance your fertility potential and increase your chances of a successful pregnancy. If you are planning for the future, consider consulting a fertility specialist for personalized guidance on preserving and optimizing your reproductive health.

loader